Aptalis Pharma Us Drug Patent Portfolio
Aptalis Pharma Us owns 1 orange book drug protected by 7 US patents Given below is the list of Aptalis Pharma Us's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7658918 | Stable digestive enzyme compositions | 20 Feb, 2028 | Active |
| US8221747 | Stable pancreatic enzyme compositions | 20 Feb, 2028 | Active |
| US8246950 | Stable digestive enzyme compositions | 20 Feb, 2028 | Active |
| US8562978 | Stable digestive enzyme compositions | 20 Feb, 2028 | Active |
| US8562979 | Stable digestive enzyme compositions | 20 Feb, 2028 | Active |
| US8562980 | Stable digestive enzyme compositions | 20 Feb, 2028 | Active |
| US8562981 | Stable digestive enzyme compositions | 20 Feb, 2028 | Active |
Latest Legal Activities on Aptalis Pharma Us's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Aptalis Pharma Us.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 07 Feb, 2024 | US8246950 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 28 Jul, 2021 | US7658918 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Feb, 2020 | US8246950 |
|
Email Notification
Critical
| 29 Sep, 2014 | US8246950 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 29 Sep, 2014 | US8246950 |
|
Email Notification
Critical
| 26 Sep, 2014 | US7658918 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 26 Sep, 2014 | US7658918 |
|
Correspondence Address Change
Critical
| 24 Sep, 2014 | US8246950 |
|
Correspondence Address Change
Critical
| 24 Sep, 2014 | US7658918 |
| Mail Pre-Exam Notice | 05 Aug, 2014 | US7658918 |
|
Email Notification
Critical
| 05 Aug, 2014 | US8246950 |
|
Electronic Review
Critical
| 05 Aug, 2014 | US7658918 |
| Mail Pre-Exam Notice | 05 Aug, 2014 | US8246950 |
|
Email Notification
Critical
| 05 Aug, 2014 | US7658918 |
|
Electronic Review
Critical
| 05 Aug, 2014 | US8246950 |
Aptalis Pharma Us's Family Patents
Aptalis Pharma Us Drug List
Given below is the complete list of Aptalis Pharma Us's drugs and the patents protecting them.
1. Zenpep
Zenpep is protected by 7 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7658918 | Stable digestive enzyme compositions |
20 Feb, 2028
(3 years from now)
| Active |
| US8221747 | Stable pancreatic enzyme compositions |
20 Feb, 2028
(3 years from now)
| Active |
| US8246950 | Stable digestive enzyme compositions |
20 Feb, 2028
(3 years from now)
| Active |
| US8562978 | Stable digestive enzyme compositions |
20 Feb, 2028
(3 years from now)
| Active |
| US8562979 | Stable digestive enzyme compositions |
20 Feb, 2028
(3 years from now)
| Active |
| US8562980 | Stable digestive enzyme compositions |
20 Feb, 2028
(3 years from now)
| Active |
| US8562981 | Stable digestive enzyme compositions |
20 Feb, 2028
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zenpep's drug page